A randomised, open label Phase 3 study of Carfilzomib, Melaphalan, and prednisone versus Bortezomib, Melaphalan, and prednisone in transplant-ineligible patients with newly diagnosed multiple myeleom

Project: Research

StatusFinished
Effective start/end date18/11/1331/12/14